GLP-1 agonists , or glucagon-like peptide-1 compounds , are representing as a remarkable breakthrough in treating diabetes mellitus . These novel therapies help increasing insulin production and https://glp1352267.activoblog.com/53573105/glp-1-a-promising-approach-in-diabetes-treatment